Back

Temporal trends and prognostic impact of comprehensive guideline-directed medical therapy in HFrEF: a 1-year follow-up from the KorHF III registry

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: optimising and intensifying guideline-directed medical therapy Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Jung Woo Son

Wonju Severance Christian Hospital, Wonju (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
In-hospital treatment intensification and outcomes in patients hospitalised for worsening heart failure in the current era of guideline-directed medical treatment
Assistant Professor T. Hashimoto (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Right ventricular–arterial uncoupling identifies acute heart failure patients with reduced tolerance to GDMT
Doctor G. Scoccia (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Impact of in-hospital intensification of heart failure medical treatment on clinical outcomes in dialysis-dependent patients with worsening heart failure
Doctor K. Ikuta (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Impact of quadruple guideline-directed medical therapy at discharge on thirty-day mortality in older adults with heart failure and reduced ejection fraction: a real-world registry.
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides Video
Presentation thumbnail
Guideline-directed medical therapy and outcomes across cardiac and noncardiac domains in systolic heart failure
Associate Professor S. Higuchi (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: optimising and intensifying guideline-directed medical therapy

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of poor adherence to guideline-directed medical treatment with adverse events including fatal arrhythmia in heart failure with reduced ejection fraction: A nationwide cohort analysis
11 May 2026
thumbnail
Congress Presentation
Efficiency of guideline-directed medical therapy in patients with acute decompensated heart failure and subclinical congestion at discharge.
19 May 2025
thumbnail
Congress Presentation
Guideline-directed medical therapy presciption after acute heart failure hospitalization in Japan
31 August 2025
thumbnail
Congress Presentation
Longitudinal trajectories of guideline-directed medical therapy and 12-month mortality in acute heart failure: insights from the KorHF-III Registry
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources